Global Interleukin 17A Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Interleukin 17A market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Interleukin 17A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Interleukin 17A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Interleukin 17A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Interleukin 17A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Interleukin 17A include Abeome Corporation, Affibody AB, Cell Medica Limited, Orega Biotech SAS, AbbVie Inc, Eli Lilly and Company, Merck KGaA, Novartis AG and Johnson & Johnson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Interleukin 17A, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Interleukin 17A, also provides the sales of main regions and countries. Of the upcoming market potential for Interleukin 17A, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Interleukin 17A sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Interleukin 17A market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Interleukin 17A sales, projected growth trends, production technology, application and end-user industry.

Interleukin 17A Segment by Company

Abeome Corporation
Affibody AB
Cell Medica Limited
Orega Biotech SAS
AbbVie Inc
Eli Lilly and Company
Merck KGaA
Novartis AG
Johnson & Johnson

Interleukin 17A Segment by Type

DLX-2882
CNTO-6785
ABY-035
Others

Interleukin 17A Segment by Application

Kidney Cancer
Chronic Pain
Liver Cancer
Others

Interleukin 17A Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interleukin 17A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Interleukin 17A and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interleukin 17A.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Interleukin 17A in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Interleukin 17A manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Interleukin 17A sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Interleukin 17A Market by Type
1.2.1 Global Interleukin 17A Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 DLX-2882
1.2.3 CNTO-6785
1.2.4 ABY-035
1.2.5 Others
1.3 Interleukin 17A Market by Application
1.3.1 Global Interleukin 17A Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Kidney Cancer
1.3.3 Chronic Pain
1.3.4 Liver Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Interleukin 17A Market Dynamics
2.1 Interleukin 17A Industry Trends
2.2 Interleukin 17A Industry Drivers
2.3 Interleukin 17A Industry Opportunities and Challenges
2.4 Interleukin 17A Industry Restraints
3 Global Market Growth Prospects
3.1 Global Interleukin 17A Revenue Estimates and Forecasts (2020-2031)
3.2 Global Interleukin 17A Revenue by Region
3.2.1 Global Interleukin 17A Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Interleukin 17A Revenue by Region (2020-2025)
3.2.3 Global Interleukin 17A Revenue by Region (2026-2031)
3.2.4 Global Interleukin 17A Revenue Market Share by Region (2020-2031)
3.3 Global Interleukin 17A Sales Estimates and Forecasts 2020-2031
3.4 Global Interleukin 17A Sales by Region
3.4.1 Global Interleukin 17A Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Interleukin 17A Sales by Region (2020-2025)
3.4.3 Global Interleukin 17A Sales by Region (2026-2031)
3.4.4 Global Interleukin 17A Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Interleukin 17A Revenue by Manufacturers
4.1.1 Global Interleukin 17A Revenue by Manufacturers (2020-2025)
4.1.2 Global Interleukin 17A Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Interleukin 17A Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Interleukin 17A Sales by Manufacturers
4.2.1 Global Interleukin 17A Sales by Manufacturers (2020-2025)
4.2.2 Global Interleukin 17A Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Interleukin 17A Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Interleukin 17A Sales Price by Manufacturers (2020-2025)
4.4 Global Interleukin 17A Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Interleukin 17A Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Interleukin 17A Manufacturers, Product Type & Application
4.7 Global Interleukin 17A Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Interleukin 17A Market CR5 and HHI
4.8.2 2024 Interleukin 17A Tier 1, Tier 2, and Tier 3
5 Interleukin 17A Market by Type
5.1 Global Interleukin 17A Revenue by Type
5.1.1 Global Interleukin 17A Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Interleukin 17A Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Interleukin 17A Revenue Market Share by Type (2020-2031)
5.2 Global Interleukin 17A Sales by Type
5.2.1 Global Interleukin 17A Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Interleukin 17A Sales by Type (2020-2031) & (W Units)
5.2.3 Global Interleukin 17A Sales Market Share by Type (2020-2031)
5.3 Global Interleukin 17A Price by Type
6 Interleukin 17A Market by Application
6.1 Global Interleukin 17A Revenue by Application
6.1.1 Global Interleukin 17A Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Interleukin 17A Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Interleukin 17A Revenue Market Share by Application (2020-2031)
6.2 Global Interleukin 17A Sales by Application
6.2.1 Global Interleukin 17A Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Interleukin 17A Sales by Application (2020-2031) & (W Units)
6.2.3 Global Interleukin 17A Sales Market Share by Application (2020-2031)
6.3 Global Interleukin 17A Price by Application
7 Company Profiles
7.1 Abeome Corporation
7.1.1 Abeome Corporation Comapny Information
7.1.2 Abeome Corporation Business Overview
7.1.3 Abeome Corporation Interleukin 17A Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Abeome Corporation Interleukin 17A Product Portfolio
7.1.5 Abeome Corporation Recent Developments
7.2 Affibody AB
7.2.1 Affibody AB Comapny Information
7.2.2 Affibody AB Business Overview
7.2.3 Affibody AB Interleukin 17A Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Affibody AB Interleukin 17A Product Portfolio
7.2.5 Affibody AB Recent Developments
7.3 Cell Medica Limited
7.3.1 Cell Medica Limited Comapny Information
7.3.2 Cell Medica Limited Business Overview
7.3.3 Cell Medica Limited Interleukin 17A Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Cell Medica Limited Interleukin 17A Product Portfolio
7.3.5 Cell Medica Limited Recent Developments
7.4 Orega Biotech SAS
7.4.1 Orega Biotech SAS Comapny Information
7.4.2 Orega Biotech SAS Business Overview
7.4.3 Orega Biotech SAS Interleukin 17A Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Orega Biotech SAS Interleukin 17A Product Portfolio
7.4.5 Orega Biotech SAS Recent Developments
7.5 AbbVie Inc
7.5.1 AbbVie Inc Comapny Information
7.5.2 AbbVie Inc Business Overview
7.5.3 AbbVie Inc Interleukin 17A Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 AbbVie Inc Interleukin 17A Product Portfolio
7.5.5 AbbVie Inc Recent Developments
7.6 Eli Lilly and Company
7.6.1 Eli Lilly and Company Comapny Information
7.6.2 Eli Lilly and Company Business Overview
7.6.3 Eli Lilly and Company Interleukin 17A Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Eli Lilly and Company Interleukin 17A Product Portfolio
7.6.5 Eli Lilly and Company Recent Developments
7.7 Merck KGaA
7.7.1 Merck KGaA Comapny Information
7.7.2 Merck KGaA Business Overview
7.7.3 Merck KGaA Interleukin 17A Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Merck KGaA Interleukin 17A Product Portfolio
7.7.5 Merck KGaA Recent Developments
7.8 Novartis AG
7.8.1 Novartis AG Comapny Information
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Interleukin 17A Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Novartis AG Interleukin 17A Product Portfolio
7.8.5 Novartis AG Recent Developments
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Comapny Information
7.9.2 Johnson & Johnson Business Overview
7.9.3 Johnson & Johnson Interleukin 17A Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Johnson & Johnson Interleukin 17A Product Portfolio
7.9.5 Johnson & Johnson Recent Developments
8 North America
8.1 North America Interleukin 17A Market Size by Type
8.1.1 North America Interleukin 17A Revenue by Type (2020-2031)
8.1.2 North America Interleukin 17A Sales by Type (2020-2031)
8.1.3 North America Interleukin 17A Price by Type (2020-2031)
8.2 North America Interleukin 17A Market Size by Application
8.2.1 North America Interleukin 17A Revenue by Application (2020-2031)
8.2.2 North America Interleukin 17A Sales by Application (2020-2031)
8.2.3 North America Interleukin 17A Price by Application (2020-2031)
8.3 North America Interleukin 17A Market Size by Country
8.3.1 North America Interleukin 17A Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Interleukin 17A Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Interleukin 17A Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Interleukin 17A Market Size by Type
9.1.1 Europe Interleukin 17A Revenue by Type (2020-2031)
9.1.2 Europe Interleukin 17A Sales by Type (2020-2031)
9.1.3 Europe Interleukin 17A Price by Type (2020-2031)
9.2 Europe Interleukin 17A Market Size by Application
9.2.1 Europe Interleukin 17A Revenue by Application (2020-2031)
9.2.2 Europe Interleukin 17A Sales by Application (2020-2031)
9.2.3 Europe Interleukin 17A Price by Application (2020-2031)
9.3 Europe Interleukin 17A Market Size by Country
9.3.1 Europe Interleukin 17A Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Interleukin 17A Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Interleukin 17A Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Interleukin 17A Market Size by Type
10.1.1 China Interleukin 17A Revenue by Type (2020-2031)
10.1.2 China Interleukin 17A Sales by Type (2020-2031)
10.1.3 China Interleukin 17A Price by Type (2020-2031)
10.2 China Interleukin 17A Market Size by Application
10.2.1 China Interleukin 17A Revenue by Application (2020-2031)
10.2.2 China Interleukin 17A Sales by Application (2020-2031)
10.2.3 China Interleukin 17A Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Interleukin 17A Market Size by Type
11.1.1 Asia Interleukin 17A Revenue by Type (2020-2031)
11.1.2 Asia Interleukin 17A Sales by Type (2020-2031)
11.1.3 Asia Interleukin 17A Price by Type (2020-2031)
11.2 Asia Interleukin 17A Market Size by Application
11.2.1 Asia Interleukin 17A Revenue by Application (2020-2031)
11.2.2 Asia Interleukin 17A Sales by Application (2020-2031)
11.2.3 Asia Interleukin 17A Price by Application (2020-2031)
11.3 Asia Interleukin 17A Market Size by Country
11.3.1 Asia Interleukin 17A Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Interleukin 17A Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Interleukin 17A Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Interleukin 17A Market Size by Type
12.1.1 SAMEA Interleukin 17A Revenue by Type (2020-2031)
12.1.2 SAMEA Interleukin 17A Sales by Type (2020-2031)
12.1.3 SAMEA Interleukin 17A Price by Type (2020-2031)
12.2 SAMEA Interleukin 17A Market Size by Application
12.2.1 SAMEA Interleukin 17A Revenue by Application (2020-2031)
12.2.2 SAMEA Interleukin 17A Sales by Application (2020-2031)
12.2.3 SAMEA Interleukin 17A Price by Application (2020-2031)
12.3 SAMEA Interleukin 17A Market Size by Country
12.3.1 SAMEA Interleukin 17A Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Interleukin 17A Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Interleukin 17A Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Interleukin 17A Value Chain Analysis
13.1.1 Interleukin 17A Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Interleukin 17A Production Mode & Process
13.2 Interleukin 17A Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Interleukin 17A Distributors
13.2.3 Interleukin 17A Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings